We are live on
!
Find out more
PL
Pluribus Labs Portfolio holdings
AUM
$54.8M
This Fund
S&P 500
This Quarter
Est. Return
-2.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25.2M
AUM Growth
-$69.7M
(-73%)
Cap. Flow
-$68.8M
Cap. Flow
% of AUM
-273.42%
Top 10 Holdings %
Top 10 Hldgs %
58.31%
Holding
244
New
16
Increased
13
Reduced
15
Closed
200
Top Buys
| 1 |
Merck
MRK
|
+$505K |
| 2 |
Blackrock
BLK
|
+$373K |
| 3 |
Prologis
PLD
|
+$358K |
| 4 |
IBM
IBM
|
+$321K |
| 5 |
Lockheed Martin
LMT
|
+$310K |
Top Sells
| 1 |
MRSH
Marsh
MRSH
|
+$1.04M |
| 2 |
Public Service Enterprise Group
PEG
|
+$879K |
| 3 |
Verizon
VZ
|
+$872K |
| 4 |
QVCGA
QVC Group Inc Series A
QVCGA
|
+$813K |
| 5 |
MasTec
MTZ
|
+$788K |
Sector Composition
| 1 | Technology | 32% |
| 2 | Consumer Discretionary | 15.05% |
| 3 | Healthcare | 13.51% |
| 4 | Communication Services | 13.02% |
| 5 | Financials | 12.62% |
Similar funds
BAM
KIP
CRCM
FA
LCM
IRF
ACI
NPGCU
Pluribus Labs's Q1 2022 Portfolio in Review
As of Q1 2022, Pluribus Labs held 244 positions worth $25.2M, down 73% from $94.8M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Pluribus Labs withdrew a net $68.8M in Q1 2022, closing 200 positions and reducing 15 holdings. Its most notable exit was Marsh, an estimated $1.04M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Pluribus Labs opened a new position in Merck worth $526K.
- Pluribus Labs's largest Q1 2022 buy was Merck: 6,405 shares worth $526K.
- Pluribus Labs added most to Apple in Q1 2022, an estimated $289K increase.
- Pluribus Labs's biggest Q1 2022 reduction was Johnson & Johnson, cutting an estimated $647K.
- Pluribus Labs fully exited Marsh in Q1 2022, selling an estimated $1.04M.
- Pluribus Labs's ten largest holdings make up 58% of its $25.2M portfolio in Q1 2022.
- Pluribus Labs opened 16 new positions and closed 200 in Q1 2022.
- Pluribus Labs's portfolio value fell 73% quarter-over-quarter to $25.2M.
Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.